Is autologous stem cell transplantation still the backbone of multiple myeloma treatment?
BCR inhibitors improving CLL patient outcomes
What novel technologies are available for myeloma?
Immunotherapy for AML and ALL: checkpoint inhibitors & CAR T-cells for B-cell ALL
John DiPersio et al.
'Chemo-free' in follicular lymphoma